Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study

Br J Clin Pharmacol. 2023 Nov;89(11):3454-3459. doi: 10.1111/bcp.15862. Epub 2023 Aug 15.

Abstract

Dapsone is employed for both non-dermatological and dermatological indications but with non-existent population pharmacokinetics (popPK) data in Nigerians. This study was therefore designed to develop a popPK model in Nigerians. Non-compartmental analysis and nonlinear mixed effects modelling were utilized for data analysis. Eleven participants administered 50 mg dapsone tablet were included in the analysis. Derived pharmacokinetic parameters were: Cmax = 1.16 ± 0.32 μg/mL, Tmax = 3.77 ± 2.40 h, and t1/2z = 30.23 ± 11.76 h. PopPK model parameter estimates with inter-individual variability were Tlag = 0.40 h (10.0%, fixed); ka = 1.78 h-1 (75.9%); V/F = 89.25 L (21.6%); and Cl/F = 1.32 Lh-1 (27.7%). Sex was significantly associated with Cl/F, and body weight with V/F. Best popPK model was one-compartment with lag time, and first-order absorption and elimination. Sex and body weight significantly influenced the clearance and distribution volume of dapsone respectively.

Keywords: infectious diseases; modelling and simulation; pharmacometrics; tropical diseases.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Body Weight
  • Dapsone* / pharmacokinetics
  • Humans
  • Models, Biological*
  • Pilot Projects

Substances

  • Dapsone